Literature DB >> 1542006

Excess levels of cysteine and homocysteine induce tibial dyschondroplasia in broiler chicks.

M W Orth1, Y Bai, I H Zeytun, M E Cook.   

Abstract

The effect of excessive levels of cysteine and homocysteine on tibial dyschondroplasia (TD) in broiler chicks was studied. In the first experiment, graded levels of L-cysteine as well as one level of L-homocysteine were supplemented to a corn-soybean-based diet adequate in sulfur amino acids. Levels equal to or above 0.5% supplemental cysteine increased the incidence of TD, and levels equal to or above 0.75% supplemental cysteine increased the severity of TD above that found in chicks fed the basal diet. Also, L-homocysteine at 0.5% induced TD. In the second experiment, graded levels of DL-homocystine were added to the basal diet to determine the threshold value of homocystine needed to induce TD, and a level of ammonium sulfate isosulfurous to 0.45% homocystine was added to a basal diet. The results showed that 0.45% DL-homocystine was the lowest level that increased the severity of TD above that found in chicks fed the basal diet and that sulfate did not induce TD. In the third experiment, a 2 x 2 factorial design was used to investigate the interaction between DL-homocystine and copper. Copper supplementation lessened the severity of TD caused by DL-homocystine. Copper supplementation also tended to improve growth, especially in birds fed DL-homocystine.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1542006     DOI: 10.1093/jn/122.3.482

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  2 in total

1.  The effect of homocysteine thiolactone and its alpha methylated derivative on bone matrix in the mouse.

Authors:  G Frauscher; S Kircher; H Höger; J Gialamas; G Lubec
Journal:  Amino Acids       Date:  1994-06       Impact factor: 3.520

2.  Chemical and biomechanical characterization of hyperhomocysteinemic bone disease in an animal model.

Authors:  Priscilla G Massé; Adele L Boskey; Israel Ziv; Peter Hauschka; Sharon M Donovan; David S Howell; David E C Cole
Journal:  BMC Musculoskelet Disord       Date:  2003-02-20       Impact factor: 2.362

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.